Exploring Molecular Imaging with Collagen-Targeted PET to Measure Real-Time Collagen Reversal
Time: 3:00 pm
day: Conference Day One
Details:
- Explore a novel case study of a 12‑week, placebo-controlled clinical trial utilizing 68Ga‑CBP8 collagen‑targeted PET to directly visualize and quantify collagen turnover in the lungs of patients with fibrotic disease
- Examine how non-invasive imaging data aligned with changes in clinical endpoints including lung function, symptom severity, and circulating biomarkers, providing a multi-dimensional view of therapeutic response
- Uncover insights on how this approach offers a translational bridge between preclinical engagement and clinical efficacy, supporting smarter, faster decision-making in antifibrotic drug development
